{"id":237197,"date":"2026-05-14T22:35:27","date_gmt":"2026-05-15T03:35:27","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/05\/dyno-therapeutics-launches-two-new-aav-capsids-and-ai-platform-for-rare-disease-therapeutic-development-at-the-2026-american-society-of-gene-cell-therapy-asgct-annual-meeting"},"modified":"2026-05-14T22:35:27","modified_gmt":"2026-05-15T03:35:27","slug":"dyno-therapeutics-launches-two-new-aav-capsids-and-ai-platform-for-rare-disease-therapeutic-development-at-the-2026-american-society-of-gene-cell-therapy-asgct-annual-meeting","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/05\/dyno-therapeutics-launches-two-new-aav-capsids-and-ai-platform-for-rare-disease-therapeutic-development-at-the-2026-american-society-of-gene-cell-therapy-asgct-annual-meeting","title":{"rendered":"Dyno Therapeutics Launches Two New AAV Capsids and AI Platform for Rare Disease Therapeutic Development at the 2026 American Society of Gene &amp; Cell Therapy (ASGCT) Annual Meeting"},"content":{"rendered":"<p><a class=\"blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/dyno-therapeutics-launches-two-new-aav-capsids-and-ai-platform-for-rare-disease-therapeutic-development-at-the-2026-american-society-of-gene-cell-therapy-asgct-annual-meeting2.jpg\"><\/a><\/p>\n<p>Dyno continues to develop impressive new AAV capsids with their AI-guided design approach!<\/p>\n<hr>\n<p>About Dyno Therapeutics.<\/p>\n<p>Dyno Therapeutics is on a mission to build high-performance genetic technologies that transform patients\u2019 lives. Dyno applies AI to build technologies for gene delivery and sequence design that advance \u201cGenetic Agency\u201d \u2014 an individual\u2019s ability to take action at the genetic level to live a healthier life \u2014 through safe, effective and widely accessible genetic treatments. With frontier AI models and high-throughput <i>in vivo<\/i> experimentation, Dyno designs optimized AAV delivery vectors that solve gene delivery challenges across a wide range of therapeutic applications including eye, muscle and CNS. Dyno partners across industries to ensure these life-transforming technologies can help as many patients as possible, including through strategic collaborations with leading gene therapy developers Astellas and Roche and with technology companies including NVIDIA. Dyno\u2019s AI-designed capsids are available for direct licensing and through the Dyno Frontiers Network. Visit <a rel=\"nofollow\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&url=http%3A%2F%2Fwww.dynotx.com&esheet=54535067&newsitemid=20260513474804&lan=en-US&anchor=www.dynotx.com&index=7&md5=16a845166f9934b1100f2db180e65aa6\" shape=\"rect\" target=\"_blank\"><a href=\"http:\/\/www.dynotx.com\">www.dynotx.com<\/a><\/a> for more information.<\/p>\n<p>\u2018Dyno Therapeutics\u2019, \u2018dyno\u2019, the Dyno logo, and mountain logo are registered trademarks of Dyno Therapeutics, Inc. All rights reserved.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dyno continues to develop impressive new AAV capsids with their AI-guided design approach! About Dyno Therapeutics. Dyno Therapeutics is on a mission to build high-performance genetic technologies that transform patients\u2019 lives. Dyno applies AI to build technologies for gene delivery and sequence design that advance \u201cGenetic Agency\u201d \u2014 an individual\u2019s ability to take action at [\u2026]<\/p>\n","protected":false},"author":636,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,412,6],"tags":[],"class_list":["post-237197","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-genetics","category-robotics-ai"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/237197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/636"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=237197"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/237197\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=237197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=237197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=237197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}